Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research ...Middle East

New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 9, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today...

Hence then, the article about alamar biosciences launches nulisaqpcr bd ptau217 assay a breakthrough in non invasive brain specific biomarker detection for alzheimer s disease research was published today ( Thursday 09/10/2025 - 11:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research )

Also on site :

• France to ditch American video conferencing services
• EU’s Kallas privately complaining about ‘dictator’ von der Leyen – Politico
• This Las Vegas Attraction Is Part Art Space, Part Theme Park—And It’s Expanding in 2026